Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2

Clinical trial NCT06283459 · COMPLETED

Trial details

NCT number: NCT06283459
Sponsor: Imunon
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

SARS CoV 2 Infection

Start date: 2024-06-04
Primary completion: 2025-03-07
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.